These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG. Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052 [Abstract] [Full Text] [Related]
10. Parathyroid hormone: new assays, new receptors. Martin KJ, Akhtar I, González EA. Semin Nephrol; 2004 Jan; 24(1):3-9. PubMed ID: 14730504 [Abstract] [Full Text] [Related]
11. The need for reliable serum parathyroid hormone measurements. Torres PU. Kidney Int; 2006 Jul; 70(2):240-3. PubMed ID: 16838038 [Abstract] [Full Text] [Related]
12. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay. Cantor T, Sci B. Nefrologia; 2003 Jul; 23 Suppl 2():69-72. PubMed ID: 12778858 [Abstract] [Full Text] [Related]
14. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Gal-Moscovici A, Popovtzer MM. Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255 [Abstract] [Full Text] [Related]